These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7541755)

  • 1. Three-phase bone scintigraphy of hydroxyapatite ocular implants.
    Leitha T; Staudenherz A; Scholz U
    Eur J Nucl Med; 1995 Apr; 22(4):308-14. PubMed ID: 7541755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularisation of ocular coralline hydroxyapatite implants.
    Menzel C; Grünwald F; Busin M; Mönks T; Hotze AL; Schomburg A; Pavics L; Biersack HJ
    Eur J Nucl Med; 1994 Dec; 21(12):1343-5. PubMed ID: 7533080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of vascularization and vascular ingrowth rate of coralline hydroxyapatite ocular implant by Tc-99m MDP bone imaging.
    Civelek AC; Pacheco EM; Natarajan TK; Wagner HN; Iliff NT
    Clin Nucl Med; 1995 Sep; 20(9):779-87. PubMed ID: 8521653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyapatite orbital implants. Scanning with technetium-99m MDP.
    Numerow LM; Kloiber R; Mitchell RJ; Molnar CP; Anderson MA
    Clin Nucl Med; 1994 Jan; 19(1):9-12. PubMed ID: 7511087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of vascularization of coralline hydroxyapatite ocular implants.
    Ferrone PJ; Dutton JJ
    Ophthalmology; 1992 Mar; 99(3):376-9. PubMed ID: 1373481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphic evaluation of coralline hydroxyapatite ocular implants. Case reports on the use of planar and SPECT bone scintigraphy.
    Toney MA; Heironimus JD; Rivera D; Hollsten D
    Clin Nucl Med; 1993 Jan; 18(1):50-2. PubMed ID: 8380761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant.
    De Potter P; Shields CL; Shields JA; Flanders AE; Rao VM
    Ophthalmology; 1992 May; 99(5):824-30. PubMed ID: 1375714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone formation in hydroxyapatite orbital implants.
    Green JP; Wojno TH; Wilson MW; Grossniklaus HE
    Am J Ophthalmol; 1995 Nov; 120(5):681-2. PubMed ID: 7485377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological correlation of technetium bone scan in vascularization of hydroxyapatite implants. A primate model.
    Pacheco EM; Civelek AC; Natarajan TK; D'Anna SA; Iliff NT; Green WR
    Arch Ophthalmol; 1997 Sep; 115(9):1173-7. PubMed ID: 9298060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants.
    Rubin PA; Popham JK; Bilyk JR; Shore JW
    Ophthalmic Plast Reconstr Surg; 1994 Jun; 10(2):96-103. PubMed ID: 7522048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of biomatrix hydroxyapatite ocular implants with technetium-99m-MDP.
    Baumgarten D; Wojno T; Taylor A
    J Nucl Med; 1993 Mar; 34(3):467-8. PubMed ID: 8382742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging versus bone scan for assessment of vascularization of the hydroxyapatite orbital implant.
    Jamell GA; Hollsten DA; Hawes MJ; Griffin DJ; Klingensmith WC; White WL; Spirnak J
    Ophthalmic Plast Reconstr Surg; 1996 Jun; 12(2):127-30. PubMed ID: 8727179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-enhanced magnetic resonance imaging assessment of hydroxyapatite orbital implants.
    Spirnak JP; Nieves N; Hollsten DA; White WC; Betz TA
    Am J Ophthalmol; 1995 Apr; 119(4):431-40. PubMed ID: 7535979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.
    Shields CL; Shields JA; Eagle RC; De Potter P
    Am J Ophthalmol; 1991 Mar; 111(3):363-6. PubMed ID: 1848039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthetic hydroxyapatite implant: a report on 65 patients.
    Jordan DR; Gilberg S; Mawn L; Brownstein S; Grahovac SZ
    Ophthalmic Plast Reconstr Surg; 1998 Jul; 14(4):250-5. PubMed ID: 9700732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of vascularization of coralline hydroxyapatite ocular implants by magnetic resonance imaging.
    Hamilton HE; Christianson MD; Williams JP; Thomas RA
    Clin Imaging; 1992; 16(4):243-6. PubMed ID: 1335353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and radiological analyses of hydroxyapatite orbital implants in rabbits.
    Sires BS; Holds JB; Archer CR; Kincaid MC; Hageman GS
    Ophthalmic Plast Reconstr Surg; 1995 Dec; 11(4):273-7. PubMed ID: 8746819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenin-enhanced bone-specific differentiation in hydroxyapatite orbital implants.
    Sires BS; Holds JB; Kincaid MC; Reddi AH
    Ophthalmic Plast Reconstr Surg; 1997 Dec; 13(4):244-51. PubMed ID: 9430300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyapatite motility implants in ocular prosthetics.
    Cowper TR
    J Prosthet Dent; 1995 Mar; 73(3):267-73. PubMed ID: 7760276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of exposed hydroxyapatite orbital implants.
    Kim YD; Goldberg RA; Shorr N; Steinsapir KD
    Ophthalmology; 1994 Oct; 101(10):1709-15. PubMed ID: 7936570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.